A noninvasive method for predicting clinically significant prostate cancer using magnetic resonance imaging combined with PRKY promoter methylation level: a machine learning study
Traditional process for clinically significant prostate cancer (csPCA) diagnosis relies on invasive biopsy and may bring pain and complications. Radiomic features of magnetic resonance imaging MRI and methylat...
Source: BMC Medical Imaging - Category: Radiology Authors: Yufei Wang, Weifeng Liu, Zeyu Chen, Yachen Zang, Lijun Xu, Zheng Dai, Yibin Zhou and Jin Zhu Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Learning | MRI Scan | Pain | Prostate Cancer | Radiology | Study | Universities & Medical Training